KRTL BioTech

Suspicious trades were made before Goldman's $2.2 billion acquisition of GreenSky, options experts say

Suspicious trades were made before Goldman's $2.2 billion acquisition of GreenSky, options experts say

Suspicious trades were made before Goldman's $2.2 billion acquisition of GreenSky, indicating insider trading, options experts said.